Alcidion Group Ltd (ALC)

Currency in AUD
0.098
-0.002(-2.00%)
Closed·
ALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0980.105
52 wk Range
0.0820.145
Key Statistics
Bid/Ask
0.098 / 0.105
Prev. Close
0.098
Open
0.105
Day's Range
0.098-0.105
52 wk Range
0.082-0.145
Volume
765.66K
Average Volume (3m)
879.56K
1-Year Change
-2%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.148
Upside
+50.51%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Alcidion Group Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.148
(+50.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Hold0.13+32.65%0.12MaintainMay 19, 2026
RBC Capital
Hold0.12+22.45%0.14MaintainFeb 27, 2026
RBC Capital
Hold0.10+2.04%0.11MaintainAug 29, 2025

Alcidion Group Ltd Earnings Call Summary for Q3/2026

  • Alcidion reported 9% YoY revenue growth to AUD 43.8M with strong cash position of AUD 15.1M and zero debt in Q3 FY2026.
  • New sales totaled AUD 11.7M in contract value, with 90% derived from recurring product revenue streams.
  • Company posted positive operating cash flow of AUD 1.7M; stock price surged 10% following earnings release.
  • Management forecasts EPS growth from 0.81 USD in Q2 FY2026 to 1.14 USD by Q1 FY2027; FY2026 EPS projected at 3.52 USD.
  • Miya Precision platform expansion continues via land-and-expand strategy, securing long-term contracts across healthcare IT market.
Last Updated: 04/29/2026, 09:42 AM
Read Full Transcript

Earnings

Latest Release
Jun 03, 2026
EPS / Forecast
-- / --
Revenue / Forecast
43.8M / --
EPS Revisions
Last 90 days

ALC Income Statement

Compare ALC to Peers and Sector

Metrics to compare
ALC
Peers
Sector
Relationship
P/E Ratio
34.0x−6.7x−0.4x
PEG Ratio
0.20−0.230.00
Price/Book
1.5x1.5x2.6x
Price / LTM Sales
2.7x10.6x3.0x
Upside (Analyst Target)
45.6%14.9%49.1%
Fair Value Upside
Unlock0.7%6.3%Unlock

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Employees
136
Market
Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
149.07M11.10%14.91M
Other Institutional Investors
114.30M8.51%11.43M
Public Companies & Retail Investors
1.08B80.39%107.96M
Total
1.34B100.00%134.3M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Australian Super Pty Ltd9.43%126,691,39712,669
AustralianSuper Balanced7.09%95,166,9439,517

FAQ

What Is the Alcidion (ALC) Stock Price Today?

The Alcidion stock price today is 0.098 AUD.

What Stock Exchange Does Alcidion Trade On?

Alcidion is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Alcidion?

The stock symbol for Alcidion is "ALC."

What Is the Alcidion Market Cap?

As of today, Alcidion market cap is 131.610M AUD.

What Is Alcidion's Earnings Per Share (TTM)?

The Alcidion EPS (TTM) is 0.003.

When Is the Next Alcidion Earnings Date?

Alcidion will release its next earnings report on Sep 02, 2026.

From a Technical Analysis Perspective, Is ALC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alcidion Stock Split?

Alcidion has split 1 times.

How Many Employees Does Alcidion Have?

Alcidion has 136 employees.

What is the current trading status of Alcidion (ALC)?

As of Jul 06, 2026, Alcidion (ALC) is trading at a price of 0.098 AUD, with a previous close of 0.098 AUD. The stock has fluctuated within a day range of 0.098 AUD to 0.105 AUD, while its 52-week range spans from 0.082 AUD to 0.145 AUD.

What Is Alcidion (ALC) Price Target According to Analysts?

The average 12-month price target for Alcidion is 0.148 AUD, with a high estimate of 0.16 AUD and a low estimate of 0.13 AUD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +50.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.